Clinical Trial Update: Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating early diffusion MRI changes after two years of treatment with natalizumab (Tysabri) in patients with multiple sclerosis; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED